Avantor, Inc. (NYSE:AVTR) Shares Sold by Thrivent Financial for Lutherans

Thrivent Financial for Lutherans decreased its position in Avantor, Inc. (NYSE:AVTR) by 2.6% during the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 3,604,233 shares of the company’s stock after selling 96,559 shares during the period. Thrivent Financial for Lutherans’ holdings in Avantor were worth $76,410,000 at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. Versant Capital Management Inc boosted its position in shares of Avantor by 2,003.6% in the 2nd quarter. Versant Capital Management Inc now owns 1,157 shares of the company’s stock worth $25,000 after buying an additional 1,102 shares in the last quarter. Blue Trust Inc. lifted its holdings in shares of Avantor by 1,830.3% in the second quarter. Blue Trust Inc. now owns 1,467 shares of the company’s stock valued at $31,000 after purchasing an additional 1,391 shares in the last quarter. TFO Wealth Partners LLC grew its position in shares of Avantor by 203,100.0% in the fourth quarter. TFO Wealth Partners LLC now owns 2,032 shares of the company’s stock valued at $46,000 after purchasing an additional 2,031 shares during the last quarter. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH purchased a new position in shares of Avantor during the 1st quarter worth approximately $93,000. Finally, ORG Partners LLC increased its stake in shares of Avantor by 5,773.0% during the 2nd quarter. ORG Partners LLC now owns 5,873 shares of the company’s stock worth $122,000 after purchasing an additional 5,773 shares in the last quarter. Hedge funds and other institutional investors own 95.08% of the company’s stock.

Insider Transactions at Avantor

In related news, CAO Steven W. Eck sold 3,525 shares of the firm’s stock in a transaction that occurred on Thursday, September 5th. The shares were sold at an average price of $25.06, for a total value of $88,336.50. Following the transaction, the chief accounting officer now owns 29,544 shares in the company, valued at $740,372.64. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Company insiders own 1.50% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on AVTR shares. Barclays increased their target price on Avantor from $25.00 to $28.00 and gave the company an “overweight” rating in a report on Monday, July 29th. Citigroup lowered Avantor from a “buy” rating to a “neutral” rating and decreased their price objective for the company from $30.00 to $23.00 in a research note on Wednesday, July 10th. Wells Fargo & Company initiated coverage on shares of Avantor in a research note on Tuesday, August 27th. They issued an “overweight” rating and a $30.00 target price for the company. Stifel Nicolaus upped their target price on shares of Avantor from $27.00 to $28.00 and gave the company a “buy” rating in a report on Monday, July 29th. Finally, Morgan Stanley boosted their price objective on shares of Avantor from $28.00 to $29.00 and gave the company an “overweight” rating in a research report on Monday, July 29th. Four equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $27.40.

Avantor Stock Down 2.6 %

Shares of NYSE AVTR opened at $26.99 on Friday. Avantor, Inc. has a 52-week low of $16.63 and a 52-week high of $28.00. The firm has a fifty day moving average of $25.04 and a 200-day moving average of $24.36. The stock has a market capitalization of $18.33 billion, a PE ratio of 69.21, a P/E/G ratio of 2.75 and a beta of 1.32. The company has a quick ratio of 1.05, a current ratio of 1.59 and a debt-to-equity ratio of 0.89.

Avantor (NYSE:AVTR) last issued its earnings results on Friday, July 26th. The company reported $0.25 earnings per share for the quarter, beating analysts’ consensus estimates of $0.23 by $0.02. The firm had revenue of $1.70 billion for the quarter, compared to analysts’ expectations of $1.70 billion. Avantor had a return on equity of 12.40% and a net margin of 5.28%. On average, analysts anticipate that Avantor, Inc. will post 1.01 EPS for the current year.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.